Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

79 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Artificial intelligence-based pathology as a biomarker of sensitivity to atezolizumab-bevacizumab in patients with hepatocellular carcinoma: a multicentre retrospective study.
Zeng Q, Klein C, Caruso S, Maille P, Allende DS, Mínguez B, Iavarone M, Ningarhari M, Casadei-Gardini A, Pedica F, Rimini M, Perbellini R, Boulagnon-Rombi C, Heurgué A, Maggioni M, Rela M, Vij M, Baulande S, Legoix P, Lameiras S; HCC-AI study group; Bruges L, Gnemmi V, Nault JC, Campani C, Rhee H, Park YN, Iñarrairaegui M, Garcia-Porrero G, Argemi J, Sangro B, D'Alessio A, Scheiner B, Pinato DJ, Pinter M, Paradis V, Beaufrère A, Peter S, Rimassa L, Di Tommaso L, Vogel A, Michalak S, Boursier J, Loménie N, Ziol M, Calderaro J. Zeng Q, et al. Among authors: campani c. Lancet Oncol. 2023 Dec;24(12):1411-1422. doi: 10.1016/S1470-2045(23)00468-0. Epub 2023 Nov 8. Lancet Oncol. 2023. PMID: 37951222
Rare primary liver cancers: An EASL position paper.
Wege H, Campani C, de Kleine R, Meyer T, Nault JC, Pawlik TM, Reig M, Ricke J, Sempoux C, Torzilli G, Zucman-Rossi J. Wege H, et al. Among authors: campani c. J Hepatol. 2024 Jul 20:S0168-8278(24)02305-5. doi: 10.1016/j.jhep.2024.06.004. Online ahead of print. J Hepatol. 2024. PMID: 39289102
Ganglioside GD2 Contributes to a Stem-Like Phenotype in Intrahepatic Cholangiocarcinoma.
Mannini A, Pastore M, Giachi A, Correnti M, Spínola Lasso E, Lottini T, Piombanti B, Tusa I, Rovida E, Coulouarn C, Andersen JB, Lewinska M, Campani C, Battula VL, Yuan B, Aureli M, Carsana EV, Peraldo Neia C, Ostano P, Tani A, Nosi D, Vanni A, Maggi L, Di Tommaso L, Comito G, Madiai S, Arcangeli A, Marra F, Raggi C. Mannini A, et al. Among authors: campani c. Liver Int. 2025 Jan;45(1):e16208. doi: 10.1111/liv.16208. Liver Int. 2025. PMID: 39726234
Hierarchically Positioning Laparoscopic Microwave Ablation in the Therapeutic Span of Early Hepatocellular Carcinoma: A Real-Life Comparative Analysis.
Cillo U, Caregari S, Barabino M, Billato I, Marchini A, Furlanetto A, Lazzari S, Brolese M, Ballo M, Biasini E, Celsa C, Sangiovanni A, Foschi FG, Campani C, Vidili G, Saitta C, Piscaglia F, Brunetto MR, Masotto A, Farinati F, Trevisani F, Zappa MA, Vitale A, Santambrogio R; ITA.LI.CA Study Group. Cillo U, et al. Among authors: campani c. Ann Surg Oncol. 2024 Dec 10. doi: 10.1245/s10434-024-16462-8. Online ahead of print. Ann Surg Oncol. 2024. PMID: 39656391
Suboptimal outcomes of sorafenib as a second-line treatment after atezolizumab-bevacizumab for unresectable hepatocellular carcinoma.
Tovoli F, Pallotta DP, Vivaldi C, Campani C, Federico P, Palloni A, Dalbeni A, Soldà C, Lani L, Svegliati-Baroni G, Garajova I, Ielasi L, De Lorenzo S, Granito A, Stefanini B, Masi G, Marra F, Lonardi S, Brandi G, Daniele B, Auriemma A, Schiadà L, Chen R, Piscaglia F; ARTE study group. Tovoli F, et al. Among authors: campani c. Dig Liver Dis. 2024 Dec;56(12):2079-2084. doi: 10.1016/j.dld.2024.07.035. Epub 2024 Aug 20. Dig Liver Dis. 2024. PMID: 39168753 Free article.
79 results